Cargando…

Favipiravir: Hyperuricaemia: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520095/ http://dx.doi.org/10.1007/s40278-021-03729-x

Ejemplares similares

Favipiravir/voriconazole: Hyperuricaemia, transaminitis and off-label use: case report
Publicado: (2021)

Favipiravir: Hyperuricaemia and acute gouty arthritis following off-label use: case report
Publicado: (2020)

Favipiravir: Hyperuricaemia and lack of efficacy following off-label use: 2 case reports
Publicado: (2022)

Favipiravir: Drug fever: case report
Publicado: (2021)

HIV, visceral leishmaniasis and Parkinsonism combined with diabetes mellitus and hyperuricaemia: A case report
por: Pandey, Krishna, et al.
Publicado: (2008)

Favipiravir: Various toxicities: 3 case reports
Publicado: (2022)

Favipiravir: Erythema and transaminase elevation: case report
Publicado: (2022)

The Management of Hyperuricaemia
por: Bayliss, Richard, et al.
Publicado: (1984)

Favipiravir: Acute generalised exanthematous pustulosis: case report
Publicado: (2021)

Azithromycin/favipiravir/hydroxychloroquine: Various toxicities: 7 case reports
Publicado: (2022)

Azithromycin/favipiravir/hydroxychloroquine: Hypoglycaemia and off label use: case report
Publicado: (2021)

Favipiravir: Liver injury following an off-label use: case report
Publicado: (2021)

Favipiravir: Acute pancreatitis following an off-label use: case report
Publicado: (2021)

Favipiravir: Lack of efficacy following off-label treatment: case report
Publicado: (2021)

Favipiravir/methotrexate interaction: Hepatotoxicity due to drug interaction: case report
Publicado: (2021)

Antineoplastics/ciclesonide/favipiravir: Pancytopenia and off-label use: case report
Publicado: (2022)

Favipiravir: Acute psychosis following off-label use: case report
Publicado: (2022)

Favipiravir/methylprednisolone: Off-label use and lack of efficacy: case report
Publicado: (2022)

Favipiravir: Bilateral foot ulcers, vasculitis and off-label use : case report
Publicado: (2021)

Colchicine/favipiravir/prednisolone: Lack of efficacy and off label use: case report
Publicado: (2021)

Azithromycin/favipiravir/hydroxychloroquine: Lack of efficacy and off-label use: case report
Publicado: (2021)

Favipiravir‐induced nephrotoxicity in a patient with COVID‐19: A case report
por: Abdelbary, Asmaa A., et al.
Publicado: (2021)

Favipiravir/levofloxacin/paracetamol: Severe thrombocytopenia and off-label use: case report
Publicado: (2021)

Ceftriaxone/favipiravir/vancomycin: Lack of efficacy and off-label use: case report
Publicado: (2022)

Toxic hepatitis case with prolonged jaundice due to Favipiravir
por: Yolacan, Ramazan, et al.
Publicado: (2022)

Favipiravir: Lack of efficacy secondary to off label use in COVID-19: Case report: case report
Publicado: (2021)

Favipiravir/loxoprofen/paracetamol: Symmetrical drug-related intertriginous and flexural exanthema: case report
Publicado: (2021)

Favipiravir/hydroxychloroquine/methylprednisolone: Nephrotoxicity following an off-label use: 2 case reports
Publicado: (2021)

Azithromycin/favipiravir/hydroxychloroquine: Ventricular tachycardia and off-label use: 2 case reports
Publicado: (2020)

Azithromycin/favipiravir: Sinus bradycardia following interaction and off label use: case report
Publicado: (2022)

Advances in the management of malignancy-associated hyperuricaemia.
por: Mahmoud, H. H., et al.
Publicado: (1998)

Favipiravir/meropenem/vancomycin: Cholestatic liver injury following off-label use: case report
Publicado: (2021)

Ciclesonide/favipiravir/lopinavir/ritonavir: Off-label use, pancytopenia and liver dysfunction: case report
Publicado: (2021)

Favipiravir/hydroxychloroquine/oseltamivir: Tonic clonic seizures following off label use: case report
Publicado: (2020)

Favipiravir: Lack of efficacy during the treatment with SARS-CoV-2 pneumonia: case report
Publicado: (2022)

Enoxaparin-sodium/favipiravir: Acute generalised exanthematous pustulosis and off-label use: case report
Publicado: (2022)

Favipiravir/tocilizumab: Increased lymphocyte count and transaminases following off-label use: 4 case reports
Publicado: (2021)

Favipiravir: Fever and elevated uric acid level following off-label therapy: 2 case reports
Publicado: (2021)

Aspirin/favipiravir: Haemolytic anaemia, decrease in his lymphocyte count and off-label use: case report
Publicado: (2021)

Dexamethasone/favipiravir/methylprednisolone: Hyperglycaemia, masking of cytokine storm and off-label use: 2 case reports
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uqc4lr9hi8i20o7j1gfnjv44s4